Correspondence 0001558370-24-010368 from SOLIGENIX, INC. (SNGX)
SOLIGENIX, INC.
Date: July 30, 2024 · CIK: 0000812796 · Accession: 0001558370-24-010368
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280993
Letter
Soligenix, Inc.
29 Emmons Drive, Suite B-10
Princeton, NJ 08540
July 30, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re:
Soligenix, Inc.
Registration Statement on Form S-1
File No. 333-280993
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933 and on behalf of Soligenix, Inc. (the “Company”), the undersigned hereby requests that the Company’s Registration Statement on Form S-1 (File No. 333-280993), as amended, be declared effective on August 2, 2024, at 4:00 p.m., Eastern Daylight Time, or as soon as practicable thereafter.
The Company hereby authorizes its counsel, Driscoll R. Ugarte of Duane Morris LLP, to orally modify or withdraw this request for acceleration. Please contact Mr. Ugarte at (561) 962-2139 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted
Very truly yours,
SOLIGENIX, INC.
Show Raw Text
CORRESP 1 filename1.htm Soligenix, Inc. 29 Emmons Drive, Suite B-10 Princeton, NJ 08540 July 30, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Soligenix, Inc. Registration Statement on Form S-1 File No. 333-280993 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933 and on behalf of Soligenix, Inc. (the “Company”), the undersigned hereby requests that the Company’s Registration Statement on Form S-1 (File No. 333-280993), as amended, be declared effective on August 2, 2024, at 4:00 p.m., Eastern Daylight Time, or as soon as practicable thereafter. The Company hereby authorizes its counsel, Driscoll R. Ugarte of Duane Morris LLP, to orally modify or withdraw this request for acceleration. Please contact Mr. Ugarte at (561) 962-2139 with any questions you may have concerning this request, and please notify him when this request for acceleration has been granted Very truly yours, SOLIGENIX, INC. By: /s/ Christopher J. Schaber Christopher J. Schaber, PhD President and Chief Executive Officer cc: Driscoll R. Ugarte, P.A. Duane Morris LLP